Background: Macrocephaly may encompass a broad array of clinical conditions, but no decisional algorithms exist for its assessment and management. The clinician–geneticist alliance in the specific context of overgrowth syndromes may be of interest for shaping a proper diagnostic path. At present, the literature regarding a genetic link of macrocephaly with pathogenic SETD2 variants is limited. Case Presentation: We report a young man with macrocephaly first noted in infancy, confirmed in every stage of his life, combined with speech delay and moderate learning disability. He came to our first evaluation due to macrocrania and a history of cognitive and behavioral impairment. Brain magnetic resonance was performed after this first visit, confirming macrocephaly and revealing type I Arnold-Chiari malformation, but neither hydrocephalus nor pituitary abnormalities. Genetic testing evaluating different genes involved in overgrowth syndromes revealed the novel variant c.7039C>T (p.Gln2347*) in the SETD2 gene, leading us to diagnose Luscan–Lumish syndrome, an autosomal dominant intellectual developmental disorder associated with protean overgrowth manifestations, including macrocephaly and dysmorphic features. Case-based Review of the Literature and Discussion: An extremely heterogeneous group of disorders with a wide range of etiologies, neurodevelopmental outcomes, and radiologic characteristics may be associated with individuals with macrocephaly. After initial clinical and neuroimaging assessment, a coherent diagnostic work-up should be customized for each case of macrocephaly to clarify an underlying condition and delineate prognosis. Genetic investigation should be considered mandatory in deciphering the inner architecture of macrocephalies and explaining any associated abnormalities that may cause either growth anomaly in se or its concurrent symptoms. Conclusions: A standard recognized classification system integrating clinical, neuroimaging, developmental biological criteria and molecular/genetic assessment of macrocephaly is not currently available; however, future investigations on patients with macrocephaly will help in understanding SETD2-related disorders and provide accurate genetic counseling for more targeted management strategies.
Rigante, D., Leoni, C., Veredice, C., Onesimo, R., Petracca, G., Polo, A., Tartaglia, M., Zampino, G., A genetic approach to characterize macrocephalies: the experience of SETD2-related overgrowth syndrome., <<DISEASES>>, 2026; 2026 (14(11):426): 1-13. [doi:10.3390/diseases14110426] [https://hdl.handle.net/10807/351236]
A genetic approach to characterize macrocephalies: the experience of SETD2-related overgrowth syndrome.
Rigante, Donato
;Leoni, Chiara;Veredice, Chiara;Onesimo, Roberta;Petracca, Giorgia;Polo, Agnese;Zampino, Giuseppe
2026
Abstract
Background: Macrocephaly may encompass a broad array of clinical conditions, but no decisional algorithms exist for its assessment and management. The clinician–geneticist alliance in the specific context of overgrowth syndromes may be of interest for shaping a proper diagnostic path. At present, the literature regarding a genetic link of macrocephaly with pathogenic SETD2 variants is limited. Case Presentation: We report a young man with macrocephaly first noted in infancy, confirmed in every stage of his life, combined with speech delay and moderate learning disability. He came to our first evaluation due to macrocrania and a history of cognitive and behavioral impairment. Brain magnetic resonance was performed after this first visit, confirming macrocephaly and revealing type I Arnold-Chiari malformation, but neither hydrocephalus nor pituitary abnormalities. Genetic testing evaluating different genes involved in overgrowth syndromes revealed the novel variant c.7039C>T (p.Gln2347*) in the SETD2 gene, leading us to diagnose Luscan–Lumish syndrome, an autosomal dominant intellectual developmental disorder associated with protean overgrowth manifestations, including macrocephaly and dysmorphic features. Case-based Review of the Literature and Discussion: An extremely heterogeneous group of disorders with a wide range of etiologies, neurodevelopmental outcomes, and radiologic characteristics may be associated with individuals with macrocephaly. After initial clinical and neuroimaging assessment, a coherent diagnostic work-up should be customized for each case of macrocephaly to clarify an underlying condition and delineate prognosis. Genetic investigation should be considered mandatory in deciphering the inner architecture of macrocephalies and explaining any associated abnormalities that may cause either growth anomaly in se or its concurrent symptoms. Conclusions: A standard recognized classification system integrating clinical, neuroimaging, developmental biological criteria and molecular/genetic assessment of macrocephaly is not currently available; however, future investigations on patients with macrocephaly will help in understanding SETD2-related disorders and provide accurate genetic counseling for more targeted management strategies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



